G Assmann

发表

The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers.

G. Assmann, P. Cullen, H. Schulte, 1997, Circulation.

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

G. Assmann, H. Schulte, H Schulte, 1988, American heart journal.

Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease.

G. Assmann, H. Schulte, H. Lenzen, 1986, Clinical chemistry.

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies

H Tunstall-Pedoe, Dan Jackson, S G Thompson, 2009, Statistics in medicine.

An improved method for quantification of cholesterol and cholesteryl esters in human monocyte-derived macrophages by high performance liquid chromatography with identification of unassigned cholesteryl ester species by means of secondary ion mass spectrometry.

A. Benninghoven, G. Assmann, P. Cullen, 1997, Journal of lipid research.

Effects of dietary fatty acids on the composition and oxidizability of low-density lipoprotein

G. Assmann, P. Cullen, M. Fobker, 2002, European Journal of Clinical Nutrition.

The Münster Heart Study (PROCAM). Results of follow-up at 8 years.

G. Assmann, P. Cullen, H. Schulte, 1998, European heart journal.

Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.

A. von Eckardstein, G. Assmann, H. Schulte, 2000, The Journal of clinical endocrinology and metabolism.

Results of the multicentre evaluation of an electrochemiluminescence immunoassay for HCG on Elecsys 2010.

D Neumeier, J P Yvert, G Assmann, 1998, Wiener klinische Wochenschrift.

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

H Tunstall-Pedoe, V Tikhonoff, A Hofman, 2007, European Journal of Epidemiology.

Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

G. Assmann, H. Schulte, H. Funke, 1990, Clinical chemistry.

c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells

G. Assmann, T. Dittmar, J. Nofer, 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport.

A. von Eckardstein, G. Assmann, H. Schulte, 1996, Atherosclerosis.

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

H Tunstall-Pedoe, Simon G Thompson, John Danesh, 2005, JAMA.

Structure-activity studies of human sterol carrier protein 2.

G. Assmann, U. Seedorf, H. Hinz, 1994, The Journal of biological chemistry.

Apolipoprotein E Polymorphism and Coronary Artery Disease

G. Assmann, G Assmann, H J Menzel, 1983, Arteriosclerosis.